Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MVA-BN-RSV Vaccine Phase II Trial in Older Adults
NCT02873286Phase 2Completed
- Sponsor
- Bavarian Nordic
- Start
- Sep 2016
- Primary completion
- Dec 2018
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of MVA-BN-RSV in respiratory syncytial virus infection (RSV), sponsored by Bavarian Nordic. Started Sep 2016; status: completed.
02
Drugs
MVA-BN-RSV
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT02873286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02873286.